Status:
COMPLETED
Correlation Between Montreal Cognitive Assessment and Voice Therapy Outcomes in the Aging Treatment- Seeking Population
Lead Sponsor:
University of California, San Francisco
Collaborating Sponsors:
Emory University
New York University
Conditions:
Cognitive Impairment
Voice Disorders
Eligibility:
All Genders
60-110 years
Phase:
NA
Brief Summary
This study will investigate if the performance on the Montreal Cognitive Assessment (MoCA) is associated or predictive of the outcomes in voice, swallowing or upper airway therapy in the older laryngo...
Eligibility Criteria
Inclusion
- 60 years or older with voice/swallowing/upper airway complaints
- Multidisciplinary assessment by fellowship-trained laryngologist and voice/swallow/upper airway specialized speech-language pathologist
- Voice, Swallowing and/or Upper airway disorder diagnosis
- Candidate for voice, swallowing or upper airway therapy following interdisciplinary assessment.
- State willingness to participate in the study protocol
Exclusion
- Under the age of 60 years old
- Previously diagnosed dementia
- Central neurological disorder
- Active psychotic disorder
- Recurrent or active major depressive disorder (PHQ-9 of 10 or greater)
- Patient not able to attempt the MoCA because of a severe hearing or visual impairment
- Patients who do not speak or understand English
- Tested with MoCA in the last month
Key Trial Info
Start Date :
March 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2023
Estimated Enrollment :
57 Patients enrolled
Trial Details
Trial ID
NCT05187910
Start Date
March 1 2021
End Date
July 1 2023
Last Update
September 26 2023
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
UCSF Voice and Swallowing Center
San Francisco, California, United States, 94115
2
Emory Voice Center
Atlanta, Georgia, United States, 30308
3
NYU Voice Center
New York, New York, United States, 10017
4
Cornell Medical Center
New York, New York, United States, 10065